(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CKS2 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1348782 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of CKS2 mRNA CTD PMID:22079256 (S)-nicotine increases expression ISO RGD:1348782 6480464 Nicotine results in increased expression of CKS2 mRNA CTD PMID:16949557 1,2-dimethylhydrazine decreases expression ISO RGD:1557386 6480464 1, 2-Dimethylhydrazine results in decreased expression of CKS2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1557386 6480464 Ethinyl Estradiol results in increased expression of CKS2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CKS2 mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO RGD:1557386 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CKS2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1557386 6480464 Ethinyl Estradiol affects the expression of CKS2 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO RGD:1348782 6480464 Estradiol results in increased expression of CKS2 mRNA CTD PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1557386 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1557386 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1557386 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CKS2 mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CKS2 mRNA CTD PMID:17942748 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1557386 6480464 Tetrachlorodibenzodioxin results in increased expression of CKS2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557386 6480464 Tetrachlorodibenzodioxin affects the expression of CKS2 mRNA CTD PMID:21570461 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1348782 6480464 2 more ... CTD PMID:17547211 , PMID:19031421 2-hydroxypropanoic acid affects expression ISO RGD:1348782 6480464 Lactic Acid affects the expression of CKS2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1348782 6480464 beta-methylcholine affects the expression of CKS2 mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1557386 6480464 Methylcholanthrene results in increased expression of CKS2 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1557386 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CKS2 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:1557386 6480464 4-hydroxy-2-nonenal results in decreased expression of CKS2 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1557386 6480464 Fenretinide results in increased expression of CKS2 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:1348782 6480464 Fluorouracil results in decreased expression of CKS2 mRNA CTD PMID:17374387 5-fluorouracil decreases expression ISO RGD:1557386 6480464 Fluorouracil results in decreased expression of CKS2 mRNA CTD PMID:19272435 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CKS2 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of CKS2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of CKS2 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1348782 6480464 Aflatoxin B1 affects the expression of CKS2 protein CTD PMID:20106945 aldehydo-D-glucose increases expression ISO RGD:1557386 6480464 Glucose results in increased expression of CKS2 mRNA CTD PMID:17178593 all-trans-retinoic acid decreases expression ISO RGD:1348782 6480464 Tretinoin results in decreased expression of CKS2 mRNA CTD PMID:21934132 antimony(0) increases expression ISO RGD:1348782 6480464 Antimony results in increased expression of CKS2 mRNA CTD PMID:17547211 aristolochic acid decreases expression EXP 6480464 aristolochic acid I results in decreased expression of CKS2 mRNA CTD PMID:17483316 arsane multiple interactions ISO RGD:1348782 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CKS2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1348782 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CKS2 mRNA CTD PMID:32525701 arsenite(3-) decreases expression ISO RGD:1557386 6480464 arsenite results in decreased expression of CKS2 mRNA CTD PMID:18929588 benzo[a]pyrene increases expression ISO RGD:1557386 6480464 Benzoapyrene results in increased expression of CKS2 mRNA CTD PMID:20504355 benzo[a]pyrene decreases methylation ISO RGD:1348782 6480464 Benzoapyrene results in decreased methylation of CKS2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1557386 6480464 Benzoapyrene results in decreased expression of CKS2 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1348782 6480464 7 more ... CTD PMID:20382639 bicalutamide decreases expression ISO RGD:1348782 6480464 bicalutamide results in decreased expression of CKS2 mRNA CTD PMID:15638997 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1348782 6480464 Mustard Gas results in decreased expression of CKS2 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1557386 6480464 Diethylhexyl Phthalate results in decreased expression of CKS2 mRNA CTD PMID:28085963 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CKS2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1348782 6480464 bisphenol A results in decreased expression of CKS2 mRNA CTD PMID:29275510 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of CKS2 mRNA CTD PMID:24136188 butan-1-ol multiple interactions ISO RGD:1348782 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKS2 mRNA CTD PMID:29432896 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CKS2 mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:1348782 6480464 Calcitriol results in decreased expression of CKS2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1348782 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CKS2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1348782 6480464 Nanotubes, Carbon results in increased expression of CKS2 mRNA CTD PMID:28673683 carbon nanotube increases expression ISO RGD:1557386 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin increases expression ISO RGD:1348782 6480464 chloropicrin results in increased expression of CKS2 mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:1348782 6480464 chloropicrin results in decreased expression of CKS2 mRNA CTD PMID:28476498 chloroprene increases expression ISO RGD:1557386 6480464 Chloroprene results in increased expression of CKS2 mRNA CTD PMID:23125180 chlorpromazine decreases expression ISO RGD:1348782 6480464 Chlorpromazine analog results in decreased expression of CKS2 mRNA CTD PMID:15924885 chromium(6+) affects expression ISO RGD:1557386 6480464 chromium hexavalent ion affects the expression of CKS2 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:1557386 6480464 Ciguatoxins affects the expression of CKS2 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:1348782 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CKS2 mRNA, Cisplatin promotes the reaction [Piroxicam results in decreased expression of CKS2 mRNA] CTD PMID:21858171 , PMID:27392435 cisplatin decreases expression ISO RGD:1348782 6480464 Cisplatin results in decreased expression of CKS2 mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:1557386 6480464 Cisplatin results in decreased expression of CKS2 mRNA CTD PMID:25270620 cobalt dichloride decreases expression ISO RGD:1348782 6480464 cobaltous chloride results in decreased expression of CKS2 mRNA CTD PMID:19376846 copper atom increases expression EXP 6480464 Copper results in increased expression of CKS2 mRNA CTD PMID:30556269 copper atom multiple interactions ISO RGD:1348782 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CKS2 mRNA CTD PMID:30911355 copper(0) increases expression EXP 6480464 Copper results in increased expression of CKS2 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1348782 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CKS2 mRNA CTD PMID:30911355 copper(II) chloride increases expression ISO RGD:1348782 6480464 cupric chloride results in increased expression of CKS2 mRNA CTD PMID:17211630 copper(II) sulfate increases expression ISO RGD:1348782 6480464 Copper Sulfate results in increased expression of CKS2 mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of CKS2 mRNA CTD PMID:15755911 coumestrol increases expression ISO RGD:1348782 6480464 Coumestrol results in increased expression of CKS2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1348782 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1348782 6480464 Asbestos, Crocidolite results in increased expression of CKS2 mRNA CTD PMID:25351596 cyclosporin A decreases expression ISO RGD:1348782 6480464 Cyclosporine results in decreased expression of CKS2 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A increases expression ISO RGD:1348782 6480464 Cyclosporine results in increased expression of CKS2 mRNA CTD PMID:25562108 cytarabine decreases expression ISO RGD:1348782 6480464 Cytarabine results in decreased expression of CKS2 mRNA CTD PMID:17374387 D-glucose increases expression ISO RGD:1557386 6480464 Glucose results in increased expression of CKS2 mRNA CTD PMID:17178593 diazinon increases methylation ISO RGD:1348782 6480464 Diazinon results in increased methylation of CKS2 gene CTD PMID:22964155 dibutyl phthalate decreases expression ISO RGD:1557386 6480464 Dibutyl Phthalate results in decreased expression of CKS2 mRNA CTD PMID:17361019 , PMID:21266533 diethylstilbestrol increases expression ISO RGD:1348782 6480464 Diethylstilbestrol results in increased expression of CKS2 mRNA CTD PMID:15766595 dioxygen increases expression ISO RGD:1557386 6480464 Oxygen deficiency results in increased expression of CKS2 mRNA CTD PMID:24205000 dioxygen decreases expression ISO RGD:1348782 6480464 Oxygen deficiency results in decreased expression of CKS2 mRNA CTD PMID:26516004 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:1348782 6480464 Antimony Potassium Tartrate results in increased expression of CKS2 mRNA CTD PMID:17547211 disodium selenite increases expression ISO RGD:1348782 6480464 Sodium Selenite results in increased expression of CKS2 mRNA CTD PMID:18175754 elemental selenium decreases expression ISO RGD:1348782 6480464 Selenium results in decreased expression of CKS2 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CKS2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1348782 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in increased expression of CKS2 mRNA CTD PMID:19167446 ethanol multiple interactions ISO RGD:1348782 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKS2 mRNA CTD PMID:29432896 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CKS2 mRNA CTD PMID:24793618 fluvastatin multiple interactions ISO RGD:1348782 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of CKS2 mRNA CTD PMID:16996129 glucose increases expression ISO RGD:1557386 6480464 Glucose results in increased expression of CKS2 mRNA CTD PMID:17178593 GW 4064 multiple interactions ISO RGD:1557386 6480464 GW 4064 promotes the reaction [NR1H4 protein binds to CKS2 gene] CTD PMID:20091679 hydroxyurea decreases expression ISO RGD:1348782 6480464 Hydroxyurea results in decreased expression of CKS2 mRNA CTD PMID:17374387 irinotecan decreases expression EXP 6480464 Irinotecan results in decreased expression of CKS2 mRNA CTD PMID:20097248 isobutanol multiple interactions ISO RGD:1348782 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CKS2 mRNA CTD PMID:29432896 leflunomide decreases expression ISO RGD:1348782 6480464 leflunomide results in decreased expression of CKS2 mRNA CTD PMID:28988120 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of CKS2 mRNA CTD PMID:24136188 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of CKS2 mRNA CTD PMID:24136188 lipopolysaccharide decreases expression ISO RGD:1557386 6480464 Lipopolysaccharides results in decreased expression of CKS2 mRNA CTD PMID:12057914 manganese atom decreases expression ISO RGD:1348782 6480464 Manganese results in decreased expression of CKS2 mRNA CTD PMID:17175027 manganese(0) decreases expression ISO RGD:1348782 6480464 Manganese results in decreased expression of CKS2 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO RGD:1348782 6480464 manganese chloride results in decreased expression of CKS2 mRNA CTD PMID:17175027 mercury atom increases expression ISO RGD:1348782 6480464 Mercury results in increased expression of CKS2 mRNA CTD PMID:17547211 mercury(0) increases expression ISO RGD:1348782 6480464 Mercury results in increased expression of CKS2 mRNA CTD PMID:17547211 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CKS2 mRNA CTD PMID:30467583 mitomycin C decreases expression ISO RGD:1557386 6480464 Mitomycin results in decreased expression of CKS2 mRNA CTD PMID:25270620 N-nitrosodiethylamine increases expression ISO RGD:1557386 6480464 Diethylnitrosamine results in increased expression of CKS2 mRNA CTD PMID:17854601 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CKS2 mRNA CTD PMID:25242409 N-nitrosodiethylamine multiple interactions ISO RGD:1557386 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CKS2 mRNA] CTD PMID:17854601 N-Nitrosopyrrolidine decreases expression ISO RGD:1348782 6480464 N-Nitrosopyrrolidine results in decreased expression of CKS2 mRNA CTD PMID:32234424 naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of CKS2 mRNA CTD PMID:24976557 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of CKS2 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1348782 6480464 Nickel results in increased expression of CKS2 mRNA CTD PMID:19031421 , PMID:25583101 nickel dichloride increases expression ISO RGD:1348782 6480464 nickel chloride results in increased expression of CKS2 mRNA CTD PMID:17547211 nicotine increases expression ISO RGD:1348782 6480464 Nicotine results in increased expression of CKS2 mRNA CTD PMID:16949557 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of CKS2 mRNA CTD PMID:24136188 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CKS2 mRNA CTD PMID:18417182 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CKS2 mRNA CTD PMID:25729387 paracetamol increases expression ISO RGD:1348782 6480464 Acetaminophen results in increased expression of CKS2 mRNA CTD PMID:21420995 PCB138 multiple interactions ISO RGD:1557386 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO RGD:1348782 6480464 perfluorononanoic acid results in decreased expression of CKS2 mRNA CTD PMID:32588087 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of CKS2 mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:1557386 6480464 Phenobarbital results in decreased expression of CKS2 mRNA CTD PMID:19363144 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased expression of CKS2 mRNA CTD PMID:29877212 phorbol 13-acetate 12-myristate increases expression ISO RGD:1348782 6480464 Tetradecanoylphorbol Acetate results in increased expression of CKS2 mRNA CTD PMID:19031421 pinosylvin decreases expression ISO RGD:1348782 6480464 pinosylvin results in decreased expression of CKS2 mRNA CTD PMID:23333577 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CKS2 mRNA CTD PMID:22484513 pirinixic acid decreases expression ISO RGD:1557386 6480464 pirinixic acid results in decreased expression of CKS2 mRNA CTD PMID:18445702 , PMID:23811191 piroxicam multiple interactions ISO RGD:1348782 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of CKS2 mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1348782 6480464 Piroxicam results in decreased expression of CKS2 mRNA CTD PMID:21858171 potassium chromate multiple interactions ISO RGD:1348782 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of CKS2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1348782 6480464 potassium chromateVI results in decreased expression of CKS2 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1557386 6480464 Pregnenolone Carbonitrile results in decreased expression of CKS2 mRNA CTD PMID:28903501 rac-lactic acid affects expression ISO RGD:1348782 6480464 Lactic Acid affects the expression of CKS2 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:1348782 6480464 resveratrol results in decreased expression of CKS2 mRNA CTD PMID:15767336 resveratrol multiple interactions ISO RGD:1348782 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CKS2 mRNA CTD PMID:19167446 retinyl acetate increases expression ISO RGD:1557386 6480464 retinol acetate results in increased expression of CKS2 mRNA CTD PMID:16772331 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CKS2 mRNA CTD PMID:28374803 selenium atom decreases expression ISO RGD:1348782 6480464 Selenium results in decreased expression of CKS2 mRNA CTD PMID:19244175 serpentine asbestos increases expression ISO RGD:1557386 6480464 Asbestos, Serpentine results in increased expression of CKS2 mRNA CTD PMID:16251409 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CKS2 mRNA CTD PMID:22431001 silicon dioxide increases expression ISO RGD:1557386 6480464 Silicon Dioxide results in increased expression of CKS2 mRNA CTD PMID:29341224 silicon dioxide increases expression ISO RGD:1348782 6480464 Silicon Dioxide results in increased expression of CKS2 mRNA CTD PMID:25351596 sodium arsenate multiple interactions ISO RGD:1348782 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CKS2 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1348782 6480464 sodium arsenite results in increased expression of CKS2 mRNA CTD PMID:25266719 , PMID:29301061 sodium fluoride increases expression ISO RGD:1557386 6480464 Sodium Fluoride results in increased expression of CKS2 protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of CKS2 mRNA CTD PMID:19281266 sulforaphane increases expression ISO RGD:1348782 6480464 sulforafan results in increased expression of CKS2 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1348782 6480464 Sunitinib results in decreased expression of CKS2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1557386 6480464 Tamoxifen affects the expression of CKS2 mRNA CTD PMID:17555576 testosterone decreases expression ISO RGD:1348782 6480464 Testosterone results in decreased expression of CKS2 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1348782 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CKS2 mRNA CTD PMID:21592394 testosterone enanthate affects expression ISO RGD:1348782 6480464 testosterone enanthate affects the expression of CKS2 mRNA CTD PMID:17440010 tetrachloroethene increases expression ISO RGD:1348782 6480464 Tetrachloroethylene results in increased expression of CKS2 mRNA CTD PMID:19031421 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CKS2 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CKS2 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CKS2 mRNA CTD PMID:23411599 , PMID:25242409 titanium dioxide increases expression ISO RGD:1557386 6480464 titanium dioxide results in increased expression of CKS2 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CKS2 mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CKS2 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CKS2 mRNA CTD PMID:25729387 trans-pinosylvin decreases expression ISO RGD:1348782 6480464 pinosylvin results in decreased expression of CKS2 mRNA CTD PMID:23333577 trimellitic anhydride increases expression ISO RGD:1557386 6480464 trimellitic anhydride results in increased expression of CKS2 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1348782 6480464 troglitazone results in decreased expression of CKS2 mRNA CTD PMID:19140230 troglitazone increases expression ISO RGD:1557386 6480464 troglitazone results in increased expression of CKS2 mRNA CTD PMID:28973697 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of CKS2 mRNA CTD PMID:24136188 tungsten increases expression ISO RGD:1557386 6480464 Tungsten results in increased expression of CKS2 mRNA CTD PMID:30912803 urethane increases expression ISO RGD:1557386 6480464 Urethane results in increased expression of CKS2 mRNA CTD PMID:16289808 urethane increases expression ISO RGD:1348782 6480464 Urethane results in increased expression of CKS2 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1348782 6480464 Valproic Acid results in increased expression of CKS2 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:1348782 6480464 Valproic Acid affects the expression of CKS2 mRNA CTD PMID:25979313 zinc atom multiple interactions ISO RGD:1348782 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CKS2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1348782 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CKS2 mRNA CTD PMID:18593933 zoledronic acid multiple interactions ISO RGD:1348782 6480464 [zoledronic acid co-treated with fluvastatin] results in increased expression of CKS2 mRNA CTD PMID:16996129